TWST
Twist Bioscience Corp
NASDAQ · Biotechnology
$49.24
+2.14 (+4.54%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 386.04M | 314.49M | 1.60B | 1.46B | 1.26B |
| Net Income | -79,625,501 | -58,381,222 | -268,607,823 | -327,760,773 | -264,222,817 |
| EPS | — | — | — | — | — |
| Profit Margin | -20.6% | -19.6% | -16.8% | -22.5% | -21.0% |
| Rev Growth | +22.8% | +22.8% | +2.4% | +7.9% | -1.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 0 | 0 | 463.90M | 416.12M | 410.07M |
| Total Equity | — | — | 1.73B | 1.48B | 1.61B |
| D/E Ratio | — | — | 0.27 | 0.28 | 0.25 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -65,057,842 | -50,350,264 | -334,543,746 | -326,178,396 | -311,202,322 |
| Free Cash Flow | — | — | -300,671,350 | -164,017,098 | -221,326,881 |